The Index of Choice: Indications of Methadone Patients' Selection of Naltrexone Treatment

References

• Braude M. D., Morrison J. M. Preclinical toxicity studies of naltrexone. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Martin W. R., Jasinski D. R., Mansky P. A. Characteristics of the blocking effects of EN-1639A (A'-eyclopropylmethyl-7,8-dihydro-14-hydroxy-normorphine). Committee on Problems of Drug Dependence. National Academy of Sciences, National Research Council, Washington, DC 1971
   Google Scholar
• Martin W. R., Jasinski D. R., Mansky P. A. Naltrexone, an antagonist for the treatment of heroin dependency. Arch. Gen. Psychiatry 1973; 28: 784–791
   PubMed Web of Science ®Google Scholar
• Resnick R. B., Washton A. M. Clinical outcome with naltrexone: Predictor variables and followup status in detoxified heroin addicts. Ann. N. Y. Acad. Sci. 1978; 311: 241–246
   PubMedGoogle Scholar
• O'Brien C. P., Greenstein R., Woody G. E. Update on naltrexone treatment. The international challenge of drug abuse, R. C. Petersen. U.S. Government Printing Office, Washington, DC 1978, NIDA Research Monograph 19, DHEW Publication ADM 78-654
   Google Scholar
• Greenstein R., . Clinical experience with naltrexone in a behavioral research study. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault, et al. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Haas N., . Naltrexone in methadone patients electing to become “drug free,”. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault, et al. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Lewis D. C, . Use of narcotic antagonists (naltrexone) in an addiction treatment program. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault, et al. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Resnick R. B. A point of view concerning treatment approaches with narcotic antagonists. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Hurzeler M., Gerwitz D., Kleber H. Varying clinical contexts for administering naltrexone. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Keegan J., Lavenduski C, Schoof K. Comments and findings from a naltrexone double blind study. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Meyer R. E., . Limitations of an extinction approach to narcotic antagonist treatment. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault, et al. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Parwatikar S., . Factors influencing success in an antagonistic treatment program. Narcotic Antagonists: Naltrexone, D. Julim, P. Renault, et al. U.S. Government Printing Office, Washington, DC 1976, NIDA Research Series Monograph 9, DHEW Publication ADM 77-387
   Google Scholar
• Fitts W. H. Manual for the Tennessee Self Concept Scale. Counselor Recordings and Tests, Nashville, Tennessee 1965
   Google Scholar
• Rotter J. B. Generalized expectancies for internal versus exteneral control of reinforcement. Psycholog. Monogr. 1966; 80(1, Whole No. 609)
   PubMedGoogle Scholar
• Phillips J. L. Statistical Thinking: A Structural Approach. Freeman, San Francisco 1973
   Google Scholar
• Greenstein R. A., et al. Naltrexone: A short-term treatment for opiate dependence. Am. J. Drug Alcohol Abuse 1981; 8: 291–300
   PubMed Web of Science ®Google Scholar
• Gold M. S., et al. Naltrexone, opiate addiction, and endorphins. Med. Res. Rev. 1982; 3(Nos. 2)211–246
   Google Scholar
• National Research Council Committee on Clinical Evaluation of Narcotic Antagonists, Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Arch. Gen. Psychiatry 1978; 35: 335–340
   PubMed Web of Science ®Google Scholar
• Ling W. Naltrexone: The clinical investigator's dilemma. The International Challenge of Drug Abuse, R. C. Peterson. U.S. Government Printing Office, Washington, DC 1978, NIDA Research Monograph 19, DHEW Publication ADM 78-654
   Google Scholar
• Bale R. N. Therapeutic communities vs methadone maintenance: A prospective controlled study of narcotic addiction treatment-Design and 1-year follow-up. Arch. Gen. Psychiatry 1980; 37: 179–193
   PubMed Web of Science ®Google Scholar
• Goodman L. A., Kruskal W. H. Measures of association for cross classifications. Ill: Approximate sampling theory. J. Am. Stat. Assoc. 1963; 58: 322
   Google Scholar
• Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. Psychol. Rev. 1977; 84: 191–215
   PubMed Web of Science ®Google Scholar
• Resnick R. B., . Naltrexone in the treatment of opiate dependence. The International Challenge of Drug Abuse, R. C. Petersen, et al. U.S. Government Printing Office, Washington, DC 1978, NIDA Research Monograph 19, DHEW Publication ADM 78-654
   Google Scholar
• Woody G. E., Blaine J. Depression in narcotic addicts: Quite possibly more than a chance association. Handbook on Drug Abuse, R. I. Dupont, et al. U.S. Government Printing Office, Washington, DC 1979
   Google Scholar
• Rosenberg M. The association between self-esteem and anxiety. Psychiatr. Res. 1962; 1: 135–152
   Google Scholar
• Judson B. A., Carney T. M., Goldstein A. Naltrexone treatment of heroin addiction: Efficacy and sefety in a double-blind dosage comparison. J. Drug Alcohol Depend. 1981; 7: 325–346
   PubMed Web of Science ®Google Scholar
• Jasinski D. R., Pevrick J. S., Griffith J. D. Human pharmacology and abuse potential of the analgesic buprenorphine. Arch. Gen. Psychiatry 1978; 35: 501–516
   PubMed Web of Science ®Google Scholar